)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Veru
Veru (VERU) investor relations material
Veru Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary11 Feb, 2026
Executive summary
Focus on late-stage clinical development of enobosarm for obesity and muscle preservation in older adults, and sabizabulin for atherosclerotic cardiovascular disease inflammation.
Positive phase II-B QUALITY trial results showed enobosarm, alone or with GLP-1 RAs, preserved lean mass and led to greater fat loss, with monotherapy preventing weight regain after semaglutide discontinuation.
Strategic shift completed with the sale of the FC2 Female Condom business in December 2024; all prior product revenues now classified as discontinued operations.
No commercial revenue in the current quarter; all revenues, costs, and expenses from discontinued operations.
Phase 2b PLATEAU clinical trial for enobosarm plus semaglutide in older obese patients to begin in Q1 2026, with interim analysis expected in Q1 2027.
Financial highlights
Net loss for the quarter was $5.3 million ($0.26 per diluted share), improved from $8.9 million ($0.61 per share) in the prior year.
Research and development expenses decreased to $1.3 million from $5.7 million year-over-year, mainly due to the completion of the QUALITY study.
General and administrative expenses fell to $4.1 million from $5.2 million, primarily due to lower share-based compensation.
Cash, cash equivalents, and restricted cash totaled $33.0 million as of December 31, 2025, up from $15.8 million at September 30, 2025.
Net working capital increased to $29.7 million from $11.1 million sequentially.
Outlook and guidance
Cash on hand is expected to fund operations through the interim analysis of the phase II-B PLATEAU study, with trial initiation in Q1 2026 and interim analysis in Q1 2027.
FDA feedback provides two regulatory pathways for enobosarm/GLP-1 RA combination approval: incremental weight loss or preservation of physical function.
Expects to continue incurring significant expenses and operating losses as drug candidates advance.
Enobosarm BMD endpoint: new regulatory path?
Why injectable semaglutide for PLATEAU study?
Funding plan post-PLATEAU interim analysis?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Veru earnings date
Q2 20267 May, 2026
Veru
Next Veru earnings date
Q2 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Veru, Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company's lead product is currently in Phase III clinical trials, and it has also initiated Phase II trials with additional compounds targeting other therapeutic areas. Veru's clinical development pipeline includes two compounds formulated with cationic polymers, one of which was designed to improve the delivery of a select class of cancer therapeutics. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage